Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00770588 · COMPLETED
Trial details
- NCT number
- NCT00770588
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-01-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.